About Mark Kamp
Form D filings for Metabolics Pharma in 2024 list Mark Kamp as director.
Mark Kamp first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Kamp in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Kamp works with at each company, as listed on that company's latest Form D.
Metabolics Pharma, Inc. · Form D, Sep 19, 2024
JD
John Dessouki
Executive officer and director
MF
Mark Finn
Director
BM
Barry Miller
Director
JB
Jay Brammer
Director
RL
Richard Larson
Chief Executive Officer and director